Meningotuberculosis in infant: a case report
Main Article Content
Abstract
Introduction: Tuberculosis caused by Mycobacterium tuberculosis is one of the top 10 causes of death among children worldwide. Objective: To report the case of a nursling with meningotuberculosis with good recovery, to inquire about the treatment of latent infection in infants after contact with tuberculosis and to observe data that lead to the early diagnosis of meningotuberculosis, avoiding sequelae of the disease. Case report: We therefore report a case of a 9-month-old infant with a concomitant mother’s treatment for pulmonary tuberculosis for 5 months, with supervised doses. Patient had been investigated for latent infection, excluding hypothesis; he had his vaccination up to date. Initially, treatment for bacterial meningitis was performed but due to worsening of general condition, change in cerebrospinal fluid, hypertensive hydrocephalus on skull tomography, associated with family history, we began treatment for tuberculous meningitis, with a good response. Comments: Tuberculous meningoencephalitis, despite being one of the main causes of infant mortality, is still a neglected disease. Diagnostic methods are not yet very effective and therefore a number of clinical, laboratory and anamnesis parameters should be taken into account for treatment to be started as soon as possible. The Ministry of Health recommends the use of rifampicin, pyrazinamide and isoniazid as a treatment for children younger than 10 years old in association with corticosteroids. Due to the disease severity and its suboptimal diagnostic capacity, the priority should still be prevention, either through vaccination or screening for latent infection.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Pang Y, Zhao A, Cohen C, Kang W, Lu J, Wang G, et al. Current status of new tuberculosis vaccine in children. Hum, Vaccin. Immunother. 2016; 2:960-970.
2. Carvalho ACC, Cardoso CAA, Martire TM, Migliori GB, Sant’anna CC. Aspectos epidemiológicos, manifestações clínicas e prevenção da TB pediátrica sob a perspectiva da Estratégia End TB. Jornal Brasileiro de Pneumologia. 2018; 44: 134-144.
3. Leonard JM. Central Nervous System Tuberculosis. Microbiology Spectrum [serial on the internet]. 2017; 5: (4). [cited 2018 November 23]. Available from: http://www.asmscience.org/content/journal/microbiolspec/10.1128/microbiolspec. TNMI7-0044-2017.
4. Rotta NT, Silva AR, Freire CF, Owlweiler L. MTB: relato de 29 casos em população pediátrica no Brasil. Revista AMRIGS, 2004; 48: 252-255.
5. Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. 2016; 4: 1-64.
6. Toorn R, Solomons R. Update on the Diagnosis and Management of Tuberculous Meningitis in Children. Seminars in Pediatric Neurology. 2014; 21: 12-18.
7. Török ME. Tuberculous meningitis: advances in diagnosis and treatment. British Medical Bulletin. 2015; 13: 117-131.
8. Albuquerque RSP, Caminha JM, Carvalho NAR, Dantas e Silva FM, Ferreira MEL, Santos JRB, et al. TB na infância: uma revisão integrativa. REAS, Revista Eletrônica Acervo Saúde [serial on the internet]. 2018: Supl 10:1144-1151. [cited 2018 November 23]. Available from: https://www.acervosaude.com.br/doc/REAS78.pdf.
9. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de Recomendações para o Controle da TB no Brasil. Brasília: Ministério da Saúde; 2011.
10. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviços. Guia de Vigilância em Saúde: volume 2. 1. ed. atual. Brasília: Ministério da Saúde; 2017.
11. Solomons RS, Wessels M, Visser DH, Donald PR, Marais BJ, Schoeman JF, et al. Uniform research case definition criteria differentiate tuberculous and bacterial meningitis in children. Clin Infect Dis. 2014; 59: 1574-578.
12. Günes A, Uluca Ü, Aktar F, Konca C, Sen V, Ece A, et al. Clinical, radiological and laboratory findings in 185 children with tuberculous meningitis at a single centre and relationship with the stage of the disease [serial on the internet]. Ital J Pediatr. 2015; 41:75 [cited 2018 November 23]. Available from: https://doi.org/10.1186/s13052-015-0186-7.
13. Paciorek M, Pihowicz A, Bursa D, Humiecka JS, Kowalska JD, Antosiewicz M, et al. Prior treatment with non anti-TB antibiotics, and the duration of symptoms have no effect on diagnostics of tuberculous meningitis. Advances in Medical Sciences. 2017; 62: 374-377.
14. Donald PR, Toorn RV. Use of corticosteroids in tuberculous meningitis. The Lancet. 2016; 387: 2585-2587.
15. Shan I, Meshram L. High dose versus low dose steroids in children with tuberculous meningitis. J Clin Neurosci. 2014; 21:761-764.